{"database": "lobbying", "table": "lobbying_activities", "rows": [[1982733, "d6dbab2e-170a-40ec-910f-60402ab854ce", "Q2", "JEFFREY J. KIMBELL & ASSOCIATES, INC.", 46038, "EAGLE PHARMACEUTICALS INC.", 2017, "second_quarter", "HCR", "Issues related to the Orphan Drug Act, FDA user fee agreements and S. 934.", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2017-07-03T12:26:28.217000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1982733"], "units": {}, "query_ms": 26.14868903765455, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}